Research & Development

免费视频在线视频观看1新超碰97在线观看任你干"你觉得未来属于中国吗?" 这位美国人的回答意味深长


  雲瑯的腦袋痛的厲害,昨晚被梁翁他們拖進丑庸的房間,剛開始的時候還有一點知覺,後來就什麼都不知道了。   他拍著雲家堆積在門口的糧包笑道︰“听說小郎準備把糧食帶去上林苑,看來已經有了計較?”免费视频在线视频观看1   就連霍去病也沒有來過,估計是被長平給禁足了,這讓雲家徹底變得安靜了下來。新超碰97在线观看   如果墨家開始追索,她不敢想那個後果。   “砰!”任你干   “你廢話很多啊,其實我應該用石灰水泡你的,現在,家里沒有石灰窯,只要用醋代替。”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo